Literature DB >> 15730491

Post-transplant diabetes mellitus: a case-control analysis of the risk factors.

Jacopo Romagnoli1, Franco Citterio, Paola Violi, Federica Cadeddu, Giuseppe Nanni, Marco Castagneto.   

Abstract

Aim of the present study was to assess, in a pair-matched analysis design, risk factors for post-transplant diabetes mellitus (PTDM) in renal transplant recipients (KTx). The incidence of PTDM was evaluated in 538 consecutive KTx in relation to their baseline immunosuppression. PTDM was defined according to the 2003 American Diabetes Association and World Health Organization experts committee definition. As risk factors for PTDM development were considered: age, family history of diabetes, body mass index (BMI), baseline immunosuppression, doses and blood levels of the immunosuppressive agents used. Baseline immunosuppression consisted of CSA, TAC and SRL + CNI. Thirty-two pair-matched controls were identified among the 538 KTx and included in the risk analysis. Significant risk factors for the development of PTDM were identified in the family history of diabetes (P < 0.02) and BMI (P < 0.05). Higher BMI and positive family history for diabetes mellitus were significant risk factors for the development of PTDM, regardless of the immunosuppressive agent used.

Entities:  

Mesh:

Year:  2005        PMID: 15730491     DOI: 10.1111/j.1432-2277.2004.00043.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  The clinical course and outcomes of post-transplantation diabetes mellitus after heart transplantation.

Authors:  Min Soo Cho; Hyo-In Choi; In-Ok Kim; Sung-Ho Jung; Tae-Jin Yun; Jae-Won Lee; Min-Seok Kim; Jae-Joong Kim
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

Review 2.  New-onset diabetes mellitus after kidney transplantation: Current status and future directions.

Authors:  Sneha Palepu; G V Ramesh Prasad
Journal:  World J Diabetes       Date:  2015-04-15

3.  New Onset Diabetes Mellitus after Transplant: The Challenge Continues.

Authors:  Fahad Aziz
Journal:  Kidney360       Date:  2021-08-26

4.  Ameliorating Metabolic Profiles After Kidney Transplantation: A Protocol for an Open-Label, Prospective, Randomized, 3-Arm, Controlled Trial.

Authors:  Saifu Yin; Ming Ma; Zhongli Huang; Yu Fan; Xianding Wang; Turun Song; Tao Lin
Journal:  Front Med (Lausanne)       Date:  2021-12-23

5.  Early Postoperative Basal Insulin Therapy versus Standard of Care for the Prevention of Diabetes Mellitus after Kidney Transplantation: A Multicenter Randomized Trial.

Authors:  Elisabeth Schwaiger; Simon Krenn; Amelie Kurnikowski; Leon Bergfeld; María José Pérez-Sáez; Alexander Frey; David Topitz; Michael Bergmann; Sebastian Hödlmoser; Friederike Bachmann; Fabian Halleck; Susanne Kron; Hildegard Hafner-Giessauf; Kathrin Eller; Alexander R Rosenkranz; Marta Crespo; Anna Faura; Andrea Tura; Peter X K Song; Friedrich K Port; Julio Pascual; Klemens Budde; Robin Ristl; Johannes Werzowa; Manfred Hecking
Journal:  J Am Soc Nephrol       Date:  2021-08       Impact factor: 14.978

6.  Prevalence and Risk Factors of New-Onset Diabetes After Transplantation (NODAT).

Authors:  Katarzyna Zielińska; Leszek Kukulski; Marta Wróbel; Piotr Przybyłowski; Michał Zakliczyński; Krzysztof Strojek
Journal:  Ann Transplant       Date:  2020-08-25       Impact factor: 1.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.